Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viral hepatitis.

F Deinhardt, I D Gust

    Bulletin of the World Health Organization
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Hepatitis A, B, and non-A, non-B are distinct viral liver diseases. While Hepatitis A is self-limiting, Hepatitis B can become chronic, leading to severe liver damage. Hepatitis non-A, non-B agents remain largely unidentified.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prevalence of human T-cell lymphotropic virus infections in Germany.

    Journal of medical virology·1994
    Same author

    [A new variant of the simian T-lymphotropic retrovirus type I (STLV-IF) in the Sukhumi colony of hamadryas baboons].

    Voprosy virusologii·1993
    Same author

    Production of human cloned antibodies specific for hepatitis D virus-encoded small and large protein.

    Journal of hepatology·1993
    Same author

    Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles.

    Vaccine·1993
    Same author

    The immune response to different doses of inactivated hepatitis A vaccine.

    Journal of hepatology·1993
    Same author

    The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis.

    Proceedings of the National Academy of Sciences of the United States of America·1992
    Same journal

    Diplomatic roles of regional coordinators for WHO Member States.

    Bulletin of the World Health Organization·2026
    Same journal

    Evaluation of an application for investments in cataract surgery, Ethiopia.

    Bulletin of the World Health Organization·2026
    Same journal

    An umbrella protocol for the clinical evaluation of diagnostics in infectious disease.

    Bulletin of the World Health Organization·2026
    Same journal

    Fundamental changes in regulation to improve access to biosimilars.

    Bulletin of the World Health Organization·2026
    Same journal

    A public-private partnership for facility-based tuberculosis screening using chest radiographs, Viet Nam.

    Bulletin of the World Health Organization·2026
    Same journal

    Ebola at a critical juncture: preparedness must outpace transmission.

    Bulletin of the World Health Organization·2026
    See all related articles

    Area of Science:

    • Hepatology
    • Virology
    • Immunology

    Background:

    • Viral hepatitis encompasses three main forms: Hepatitis A, Hepatitis B, and Hepatitis non-A, non-B.
    • Each form presents unique etiological agents, transmission routes, and clinical outcomes.
    • Understanding these differences is crucial for diagnosis, treatment, and prevention strategies.

    Purpose of the Study:

    • To delineate the distinct characteristics of Hepatitis A, B, and non-A, non-B.
    • To summarize current knowledge on their causative agents, transmission, chronicity, and potential complications.
    • To highlight the status of vaccine development for Hepatitis A and B.

    Main Methods:

    • Review of existing literature on viral hepatitis.
    • Comparative analysis of etiological agents, transmission pathways, and disease progression.

    Related Experiment Videos

  • Summary of vaccine development efforts for Hepatitis A and B.

    • Main Results:

    • Hepatitis A: caused by picornavirus, fecal-oral transmission, non-chronic, no carriers; vaccines in development.
    • Hepatitis B: enveloped DNA virus, parenteral/close contact transmission, can be chronic, leading to cirrhosis/cancer; inactivated vaccine available, others in development.
    • Hepatitis non-A, non-B: agents unidentified, distinct parenteral and oral forms exist; oral form possibly picornavirus unrelated to Hepatitis A.

    Conclusions:

    • Hepatitis A and B are well-characterized viral infections with distinct clinical trajectories and vaccine availabilities.
    • Hepatitis non-A, non-B remains a diagnostic challenge due to unidentified agents, necessitating further research.
    • Distinguishing between parenteral and oral transmission routes for non-A, non-B hepatitis is essential for epidemiological control.